Vella Venanzio, Govender Thiloshini, Dlamini Sicelo S, Moodley Indres, David Verona, Taylor Myra, Jinabhai Champaklal C
Italian Cooperation, Department of Health, KwaZulu-Natal, South Africa.
AIDS Care. 2011 Sep;23(9):1146-53. doi: 10.1080/09540121.2011.554517. Epub 2011 May 23.
There is paucity of information on the cost-effectiveness of delivery strategies to retain patients on antiretroviral therapy (ART) and this study tries to fill this gap.
The analysis is based on a representative sample of 2835 patients attending 32 ART sites in KwaZulu-Natal (KZN), South Africa. Extended Cox regression and Kaplan Meier were used to estimate the transition probabilities to remain on ART among patients who attended sites with different staff and workload profiles. Annual costs per patient-year of observation for these delivery profiles were estimated. Probabilistic sensitivity analysis took into account parameters' uncertainty.
The delivery sites with a full-time doctor and a full-time senior professional nurse and an intake of less than 200 new patients per doctor per year were the most cost-effective in retaining patients on ART. If 1000 new patients were followed up by this type of site, 724 patients would still be on ART after 10 years at a discounted cost of US$8.41 million at 2006 value with an incremental cost-effectiveness ratio of US$12,271 per extra retained patient over the second not dominated site profile.
The results could be used to estimate the human resources needed for a sustainable scaling up of ART in KZN.
关于采用何种交付策略来使患者持续接受抗逆转录病毒治疗(ART)的成本效益,目前信息匮乏,本研究旨在填补这一空白。
该分析基于南非夸祖鲁 - 纳塔尔省(KZN)32个ART治疗点的2835名患者的代表性样本。采用扩展Cox回归和Kaplan Meier方法来估计在不同人员配备和工作量情况的治疗点就诊的患者持续接受ART治疗的转移概率。估算了这些交付模式下每位患者每年观察期的成本。概率敏感性分析考虑了参数的不确定性。
配备全职医生、全职高级专业护士且每位医生每年接收新患者少于200例的治疗点,在使患者持续接受ART治疗方面最具成本效益。如果这类治疗点随访1000名新患者,10年后724名患者仍将接受ART治疗,按2006年价值计算的贴现成本为841万美元,与第二个非劣势治疗点模式相比,每多保留一名患者的增量成本效益比为12271美元。
该结果可用于估算KZN地区可持续扩大ART治疗规模所需的人力资源。